Written question asked by Tim Farron (Liberal Democrat) on Friday, 17 September 2021, in the House of Commons. It was due for an answer on Tuesday, 21 September 2021. It was answered by Maria Caulfield (Conservative) on Tuesday, 26 October 2021 on behalf of the Department of Health and Social Care.
Chemotherapy and Radiotherapy: Finance
- Question
-
To ask the Secretary of State for Health and Social Care, what steps he is taking to address the imbalance between chemotherapy and radiotherapy spending.
- Answer
-
The differential level of spending between different services and treatments is a feature of cost and volume. Levels of spending on chemotherapy is due to greater activity, drug, staff, equipment and facility costs.
However, significant investment has been made in radiotherapy, including £32 million to replace 17 Linear Accelerators aged over 10 years by the end of March 2022. Progress ontinues to be made in the range and availability of innovative radiotherapy, where the evidence base supports it through NHS England and NHS Improvement’s clinical commissioning policy process.
Secondary information
- Type
- Written question
- Reference
- 50970
- Session
- 2021-22
- Subjects
- Finance Radiotherapy Chemotherapy
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2021-10-26 12:06:52 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2021-22/50970
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2021-22/50970
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2021-22/50970